+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Angioedema Drug"

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 146 Pages
  • Global
From
Global Hereditary Angioedema Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Hereditary Angioedema Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Angioedema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Angioedema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 81 Pages
  • Global
From
Hereditary Angioedema Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Hereditary Angioedema Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • March 2024
  • 96 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 79 Pages
  • Global
From
Loading Indicator

The Angioedema Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat angioedema, a condition characterized by swelling of the skin and mucous membranes. These drugs are typically used to reduce the severity of symptoms, such as hives, itching, and swelling of the face, lips, tongue, and throat. Commonly prescribed drugs include antihistamines, corticosteroids, and epinephrine. In some cases, angioedema drugs may be used in combination with other medications to provide a more comprehensive treatment plan. The Angioedema Drug market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Sanofi, GlaxoSmithKline, Pfizer, Novartis, and Mylan. Other companies, such as Allergan, Merck, and Teva, also offer products for the treatment of angioedema. Show Less Read more